Type II hyperprolinemia:: a case report

被引:0
|
作者
Önenli-Mungan, N
Yüksel, B
Elkay, M
Topaloglu, AK
Baykal, T
Özer, G
机构
[1] Cukurova Univ, Fac Med, Dept Pediat Endocrinol & Metab, Adana, Turkey
[2] Cukurova Univ, Fac Med, Dept Pediat Neurol, Adana, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Pediat Metab & Nutr, Istanbul, Turkey
关键词
hyperprolinemia;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hyperprolinemia type II (HP II) is a rare inherited metabolic disease due to the deficiency of pyroline-5-carboxylate dehydrogenase. It is generally believed to be a benign condition although some patients have neurological problems such as refractory convulsions. Here we report a six-year-old girl with HP II who admitted to our hospital with recurrent seizure refractory to multiple antiepileptic drugs. She was the third child of healthy, consanguineous parents. The family history was negative for neurological and renal disorders. On physical examination, she had no facial dysmorphy; the anthropometric measurements, and systemic and neurological examinations were normal. Mental and motor development was appropriate for her age. Laboratory findings revealed elevated levels of proline, glycine, and ornithine in serum and pyrroline-5-carboxylate and hydroxproline in urine. Cerebral computerized tomography and magnetic resonance imaging were both normal. Electroencephalogram showed a very active epileptic abnormality; partial control of seizures was achieved by two antiepileptics. Increased plasma glycine and ornithine levels are the unique features of our case when compared to the other HP II cases reported in the literature.
引用
收藏
页码:167 / 169
页数:3
相关论文
共 50 条
  • [11] TYPE-II HYPERPROLINEMIA IN A PEDIGREE OF IRISH TRAVELERS (NOMADS)
    FLYNN, MP
    MARTIN, MC
    MOORE, PT
    STAFFORD, JA
    FLEMING, GA
    PHANG, JM
    ARCHIVES OF DISEASE IN CHILDHOOD, 1989, 64 (12) : 1699 - 1707
  • [12] The Three-Dimensional Structural Basis of Type II Hyperprolinemia
    Srivastava, Dhiraj
    Singh, Ranjan K.
    Moxley, Michael A.
    Henzl, Michael T.
    Becker, Donald F.
    Tanner, John J.
    JOURNAL OF MOLECULAR BIOLOGY, 2012, 420 (03) : 176 - 189
  • [13] Type I hyperprolinemia
    Shivananda
    Christopher R.
    Kumar P.
    The Indian Journal of Pediatrics, 2000, 67 (7) : 541 - 543
  • [14] Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance
    Humbertclaude, V
    Rivier, F
    Roubertie, A
    Echenne, B
    Bellet, H
    Vallat, C
    Morin, D
    JOURNAL OF CHILD NEUROLOGY, 2001, 16 (08) : 622 - 623
  • [15] TYPE-I HYPERPROLINEMIA
    LAMBOTTE, C
    CHARLIER, G
    DUCULOTH.
    ARCHIVES FRANCAISES DE PEDIATRIE, 1973, 30 (09): : 1005 - 1006
  • [16] GALACTOSEMIA TYPE II: A CASE REPORT
    Bal, M. O.
    Monti, S.
    Bettocchi, I
    Baronio, F.
    Cassio, A.
    Cicognani, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S172 - S172
  • [18] PSEUDOHYPOALDOSTERONISM TYPE II: A CASE REPORT
    Wang, Liang
    Guo, Xiaoxiao
    Zhang, Shuyang
    Guo, Fan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 3441 - 3441
  • [20] HYPERPROLINEMIA TYPE-2
    DOOLEY, KC
    APPLEGARTH, DA
    CLINICAL BIOCHEMISTRY, 1978, 11 (02) : P3 - P3